Orthotopic Injection of Pancreatic Cancer Cells

Cold Spring Harb Protoc. 2016 Jan 4;2016(1):pdb.prot078360. doi: 10.1101/pdb.prot078360.

Abstract

Pancreatic ductal adenocarcinoma is an aggressive disease with a 5-yr survival rate of only 5%. The location of the pancreas in the abdomen, where it is obscured by other organs, makes it a difficult tissue to study and manipulate. This protocol describes in detail how to orthotopically inject cancer cells into the pancreas in mice. This technique is particularly useful when the cells must be manipulated in ways that cannot be modeled genetically.

MeSH terms

  • Animals
  • Cell Line, Tumor
  • Cell Separation / methods*
  • Epithelial Cells / physiology*
  • Epithelial-Mesenchymal Transition / genetics
  • Epithelial-Mesenchymal Transition / physiology*
  • Mice
  • Neoplasm Transplantation
  • Pancreatic Neoplasms / pathology*